Colistin therapy for multidrug-resistant Gram-negative infection: clinical outcome and risk factors

被引：0
作者：
Y. H. Jun
S. J. Jeun
S. H. Kang
H. J. Choi
机构：
[1] Ewha Womans University,Division of Infectious Disease, Department of Internal Medicine
[2] Mokdong Hospital,undefined
来源：
Infection | 2013年 / 41卷
关键词：
Colistin; Continuous Renal Replacement Therapy; Microbiological Response; Poor Clinical Response; Colistin Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1195 / 1198
页数：3
相关论文
共 48 条
[1]  
Paterson DL(2006)The epidemiological profile of infections with multidrug resistant Clin Infect Dis 43 543-548
[2]  
Souli M(2008) and Euro Surveill 13 1-11
[3]  
Galani I(2011) species Yonsei Med J 52 793-802
[4]  
Giamarellou H(2005)Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe Int J Antimicrob Agents 26 504-507
[5]  
Lee K(2006)The KONSAR group. Further increases in Carbapenem-, Amikacin-, and Fluoroquinolone-resistant isolates of Lancet Infect Dis 6 589-601
[6]  
Kim MN(2010) spp. and Int J of Antimicrob Agents 35 194-199
[7]  
Kim JS(2011) in Korea: KONSAR study 2009 Ann Intensive Care 1 14-519
[8]  
Hong HL(2008)Nephrotoxicity of intravenous colistin: a prospective evaluation Swiss Med Wkly 138 512-1153
[9]  
Kang JO(2010)Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections Infect Control Hosp Epidemiol 11 1148-undefined
[10]  
Shin JH(undefined)Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients undefined undefined undefined-undefined
12345